Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rangering i aksjer #33690
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Aksjekurs
$4.70
Sist synkronisert: 2026-08-14
Markedsverdi
$7.09M
Endring (1 dag)
-0.21%
Endring (1 år)
-70.63%
Land
US
Handel Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

Aksjeprishistorikk for Apimeds Pharmaceuticals US, Inc (APUS)
Høyeste sluttskurs: $4.53 den 2026-08-01

Laveste sluttskurs: $18.03 den 2025-05-01
Aksjeprishistorikk for Apimeds Pharmaceuticals US, Inc fra 2025 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -15.19%
2025 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$734.04 6.81%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE